Clinical trial / 2016
A low dose of the dietary supplement TA-65 significantly increased telomere length over 12 months compared to telomere loss with placebo.
A 1-year randomized, double-blind, placebo-controlled study evaluated telomere length changes with the dietary supplement TA-65 in 117 CMV-positive subjects aged 53-87 years. Subjects taking a low dose of TA-65 (250 U) significantly increased telomere length over 12 months (530 ± 180 bp; p = 0.005), whereas the placebo group experienced significant telomere loss (290 ± 100 bp; p = 0.01). The high-dose group (1000 U) showed a trend toward improvement compared to placebo that did not reach statistical significance.
- Study type
- Randomized, double-blind, placebo-controlled trial
- Who was studied
- 117 relatively healthy cytomegalovirus-positive subjects aged 53-87 years old
- What was measured
- Telomere length changes over a 1-year period
THE PAPER
A Natural Product Telomerase Activator Lengthens Telomeres in Humans: A Randomized, Double Blind, and Placebo Controlled Study.
Salvador L, Singaravelu G, Harley CB, Flom P, Suram A, Raffaele JM. Rejuvenation Res, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.